Health
Pfizer to Seek FDA Approval for COVID-19 Vaccine After Election – Latin Post
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
As Pfizer CEO Albert Bourla said in an open letter, their COVID-19 vaccine cannot request for emergency FDA approval before the third week of November.
The timeline is only based on Pfizer’s best estimates and does not account for delays on the COVID-19 vaccine, said an Associated Press report.
Bourla said that if they do ask for FDA approval, t…
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General23 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News16 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News13 hours agoTips to improve engagement – Proctor